Cargando…
Case Report: Significant Efficacy of Pyrotinib in the Treatment of Extensive Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Cutaneous Metastases: A Report of Five Cases
BACKGROUND: Breast cancer (BC) is the most common tumor to develop cutaneous metastases. Most BCs with cutaneous metastasis are human epidermal growth factor receptor 2 (HER2)-positive subtypes. Although the molecular mechanisms of breast cancer metastasis to different sites and the corresponding tr...
Autores principales: | Wang, Nan, Li, Lin, Xiong, Youyi, Chi, Jiangrui, Liu, Xinwei, Zhong, Chaochao, Wang, Fang, Gu, Yuanting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716402/ https://www.ncbi.nlm.nih.gov/pubmed/34976791 http://dx.doi.org/10.3389/fonc.2021.729212 |
Ejemplares similares
-
Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer
por: Wang, Nan, et al.
Publicado: (2022) -
Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
por: Wang, Nan, et al.
Publicado: (2021) -
Identification of novel prognostic risk signature of breast cancer based on ferroptosis-related genes
por: Wang, Nan, et al.
Publicado: (2022) -
The Durable Effect of Pyrotinib Plus Trastuzumab and Chemotherapy in HER2-Positive Gastric Cancer With Brain Metastases: A Case Report and Literature Review
por: Wang, Xinwei, et al.
Publicado: (2022) -
Pyrotinib in the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancer: A case report
por: Dai, Jiali, et al.
Publicado: (2020)